rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Astrazeneca

Rediff.com  »  News  »   Astrazeneca

  News for Astrazeneca

  • Business

US court rejects Ranbaxy' plea to block launch by rival cos

A US court has denied a request by drugmaker Ranbaxy Laboratories Ltd to stop competitors from launching copies of AstraZeneca Plc's heartburn pill Nexium and Roche's antiviral Valcyte, a court......

AstraZeneca rejects Pfizer's final deal offer

Britain's AstraZeneca on Monday rejected a sweetened and "final" offer from Pfizer , casting serious doubt on the U.S. drugmaker's plan for a merger to create the world's biggest pharmaceuticals......

Astrazeneca rejects latest Pfizer approach

AstraZeneca's board said on Friday it had rejected an improved $106 billion takeover offer from US drugmaker Pfizer, saying the bid which was announced just hours ago undervalued the firm.......

Aurbindo Pharma inks deal with AstraZeneca

Drugmaker Aurobindo Pharma on Monday said it has entered into licensing and supply agreements with London-based pharmaceutical giant AstraZeneca to supply several solid dosage and sterile products......

AstraZeneca India to delist scrip

AstraZeneca Pharma India, the Indian subsidiary of AstraZeneca Pharmaceuticals AB, Sweden, has decided to delist its scrip from the Bombay Stock Exchange, National Stock Exchange and Bangalore......
  Web results for Astrazeneca
Early Data Demonstrate Clinical Activity of Acalabrutinib in Difficult-to-Treat Chronic Lymphocytic Leukaemia

AstraZeneca and its haematology Centre of Excellence, Acerta Pharma, announced preliminary results from the Phase I/II ACE-CL-001 clinical trial of... ...

http://businesswireindia.com/news/news-details/early-data-demonstrate-clinical-activity-acalabrutinib-difficult-to-treat-chronic-lymphocytic-leukaemia/51261
Research and Markets - Biobanking Technologies - Expected to Reach $240.2 Billion in 2021 - Key Vendors are..

/PRNewswire/ -- Research and Markets has announced the addition of the "Biobanking: Technologies and Global Markets" report to their offering.... ...

http://in.advfn.com/news_Research-and-Markets-Biobanking-Technologies-E_73065564.html
Sensex & Nifty Remain Lackluster; M&M; Up 1.8%

Posted by Equitymaster The Indian share markets continues to trade flat during the noon trading session amid weakness in global markets. Sectoral... ...

http://www.equitymaster.com/tm/tm.asp?date=12/5/2016&title=Sensex--Nifty-Remain-Lackluster-MM-Up-18
Alembic Pharma Gets US Drug Regulator's Nod For Anti-Migraine Drug

New Delhi : Alembic Pharmaceuticals has received approval from the US health regulator for Zolmitriptan Orally Disintegrating tablets, used for the... ...

http://profit.ndtv.com/news/pharma/article-alembic-pharma-gets-us-drug-regulators-nod-for-anti-migraine-drug-1634108
Further clinical data for lirilumab and IPH4102 presented at ASH annual meeting

GlobeNewswire 2016-12-05 Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH) today announces that clinical data for lirilumab... ...

http://www.bizwireexpress.com/showstoryGNW.php?storyid=146643

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z